Annual report pursuant to Section 13 and 15(d)

NET LOSS PER SHARE (Tables)

v3.24.1.u1
NET LOSS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings per Shares, basic and diluted
The table below sets forth a reconciliation of the basic and diluted earnings per share (“EPS”) calculations for the years ended December 31, 2023 and 2022:
For the Year Ended December 31,
($ in thousands, except share and per share amounts) 2023 2022
Numerator:
Net loss $ (167,042) $ (106,200)
Denominator:
Weighted average shares outstanding - basic 83,808,227  75,710,904
Effect of dilutive equity awards (1)
—  — 
Weighted average shares outstanding - diluted 83,808,227  75,710,904 
Net loss per share:
Basic $ (1.99) $ (1.40)
Diluted $ (1.99) $ (1.40)

(1) Due to the Company’s net loss, all unvested equity awards and the private placement warrants are anti-dilutive. The dilutive convertible instruments of the Backstop Notes are out of the money.
Schedule of Diluted Shares Outstanding
Set forth in the table below is the number of securities not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:

For the Year Ended December 31,
2023 2022
Grants of RSUs with service only (i.e., time-vesting) conditions 6,193,746  3,552,416 
Common stock issuable under the Backstop Notes 9,600,031  9,600,031 
Private placement warrants
272,779  272,779